why choose us

First received: October 24, 2022

Clinical Trial: Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gram-negative Bacterial Infections

Study Type: INTERVENTIONAL


Official Title: A PHASE 2A MULTICENTER, OBSERVER-BLINDED, RANDOMIZED 2 ARM STUDY TO INVESTIGATE PHARMACOKINETICS, SAFETY, TOLERABILITY AND EFFICACY OF INTRAVENOUS AZTREONAM-AVIBACTAM ± METRONIDAZOLE COMPARED TO BEST

Brief Summary: The purpose of this study is to evaluate how Aztreonam (ATM) and Avibactam (AVI) are processed in pediatric participants.This study also aims to understand participant safety and effects in pediatric participants.The study is seeking participants who are:9 months to less than 18 years of ageHospitalizedSuspected/known to have a gram-negative infectionReceiving intravenous (iv, given directly into a vein) antibioticsBeing treated for complicated infections of various body parts that includes the abdomen,…

Read more